[mwai_chatbot id="default" stream="1" typing="1"]

Target Validation

Confirm biological relevance and reduce discovery risk with advanced gene editing, engineered cellular models, and functional biology assays.

BioDuro combines CRISPR-Cas technologies, stable cell line generation, target-based assays, and translational biology expertise to help validate therapeutic targets, understand mechanism of action, and support informed progression through hit validation and lead optimization.

Partner With Us
More information?
Contact us

Target Validation Capabilities

Target validation is essential for confirming biological relevance and reducing discovery risk before significant resources are committed to a drug discovery program. BioDuro develops customized cellular models and functional assays that help researchers investigate target function, evaluate mechanism of action, and generate the biological evidence needed to support discovery decisions.

Gene Editing & Cell Engineering

Develop customized cellular models to investigate target function and biological relevance using advanced genome engineering technologies.

  • CRISPR-Cas Gene Editing
  • Knock-Out (KO) Models
  • Stable Cell Line Generation
  • Target Gene Overexpression

Functional Target Validation

Evaluate target activity and biological response using targeted cellular and molecular assay platforms.

  • Target-Based Assays
  • Protein Marker-Based Assays
  • Mechanism-of-Action Studies
  • Pathway Biology Evaluation
  • Functional Characterization

Translational Biology Support

Generate actionable biological insights that support informed decision-making throughout discovery programs.

  • Target Engagement Assessment
  • Translational Biology Workflows
  • Hit Validation Support
  • Lead Optimization Support
  • Discovery Program Integration

Related Resources

Explore scientific resources highlighting BioDuro’s approach to target validation, mechanism-of-action studies, and biological characterization. These examples demonstrate how advanced biology platforms support informed discovery decisions and accelerate therapeutic development.

See all resources
RIPTACs for Precision Cancer Therapy In Vitro Profiling of Halda’s Patented Molecule
Whitepaper Biology

RIPTACs for Precision Cancer Therapy: In Vitro Profiling of Halda’s Patented Molecule

Explores BioDuro's integrated in vitro platform for RIPTAC profiling, enabling mechanism validation, tumor selectivity, and precision oncology discovery....
Stat6 protac discovery biology platform
Whitepaper Biology

STAT6 PROTAC Discovery Biology Platform: Representative Assay and Disease-Model Data using Kymera I-1 as the Primary Benchmark Degrader

Explores BioDuro's integrated STAT6 degrader evaluation platform, enabling comprehensive in vitro profiling to accelerate targeted protein degradation rese...
Hit to PCC in 16 Months
Case study Biology Chemistry DMPK

Integrated Drug Discovery (IDD): Hit to PCC in 16 Months

Discover how BioDuro' s integrated drug discovery platform accelerated a novel kinase inhibitor for inflammatory disease from initial hit identification to...

Related Biology Services

Target validation is often integrated with complementary biology services that help advance programs from target identification through lead optimization. Explore additional biology capabilities available through BioDuro’s discovery platform.

Peptide Biology CNS & Pain Oncology Metabolic & Cardiovascular Immunology & Inflammation Cellular Disease Models Cell Biology Cell Line Engineering Biophysics Biochemistry